CDLX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CDLX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Cardlytics's Other Financing for the three months ended in Sep. 2024 was $0.0 Mil.
Cardlytics's Other Financing for the trailing twelve months (TTM) ended in Sep. 2024 was $-19.8 Mil.
The historical data trend for Cardlytics's Other Financing can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cardlytics Annual Data | |||||||||||||||||||
Trend | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | ||||||||||
Other Financing | Get a 7-Day Free Trial | -0.34 | -26.83 | -0.39 | -0.33 | -50.05 |
Cardlytics Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Other Financing | Get a 7-Day Free Trial | -0.01 | 0.06 | -20.31 | 0.50 | - |
Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges
Other Financing for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-19.8 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Cardlytics's Other Financing provided by GuruFocus.com. Please click on the following links to see related term pages.
Clifford Sosin | 10 percent owner | 8 WRIGHT STREET, 1ST FL, WESTPORT CT 06880 |
Alexis Desieno | officer: Chief Financial Officer | C/O CARDLYTICS, INC., 675 PONCE DE LEON AVENUE NE, SUITE 6000, ATLANTA GA 30308 |
Amit Gupta | officer: Chief Operating Officer | C/O CARDLYTICS, INC, 675 PONCE DE LEON AVENUE NE, SUITE 6000, ATLANTA GA 30308 |
Nicholas Hollmeyer Lynton | officer: Chief Legal & Privacy Officer | C/O CARDLYTICS, INC., 675 PONCE DE LEON AVENUE NE, SUITE 6000, ATLANTA GA 30308 |
Klinck John L. Jr. | director | C/O STATE STREET CORPORATION, ONE LINCOLN STREET, BOSTON MA 02111 |
Scott A Hill | director | INTERCONTINENTALEXCHANGE, INC., 2100 RIVEREDGE PKWY. STE. 500, ATLANTA GA 30328 |
Karim Saad Temsamani | director, officer: Chief Executive Officer | C/O CARDLYTICS, INC., 675 PONCE DE LEON AVENUE NE, SUITE 6000, ATLANTA GA 30308 |
Alex Mishurov | director | C/O CARDLYTICS, INC., 675 PONCE DE LEON AVE. NE, SUITE 6000, ATLANTA GA 30308 |
Andrew Christiansen | officer: Chief Financial Officer | C/O CARDLYTICS, INC., 675 PONCE DE LEON AVENUE NE, SUITE 6000, ATLANTA GA 30308 |
Chris Suh | director | C/O CARDLYTICS, INC., 675 PONCE DE LEON AVE. NE, STE 6000, ATLANTA GA 30308 |
Jessica Jensen | director | C/O CARDLYTICS, INC., 675 PONCE DE LEON AVENUE NE, SUITE 6000, ATLANTA GA 30308 |
John V Balen | director | |
Scott D. Grimes | director, officer: Chief Executive Officer | CARDLYTICS, INC., 675 PONCE DE LEON AVENUE NE, SUITE 6000, ATLANTA GA 30308 |
Lynne Marie Laube | director, officer: Chief Operating Officer | C/O CARDLYTICS, INC., 675 PONCE DE LEON AVENUE NE, SUITE 6000, ATLANTA GA 30308 |
Kirk Somers | officer: Chief Legal & Privacy Officer |
From GuruFocus
By Marketwired • 08-13-2024
By PRNewswire • 08-16-2024
By Marketwired • 09-26-2024
By PRNewswire • 08-18-2024
By GuruFocus News • 11-07-2024
By Marketwired • 09-05-2024
By PRNewswire • 08-27-2024
By Marketwired • 10-23-2024
By Marketwired • 08-27-2024
By Business Wire • 08-14-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.